Need professional-grade analysis? Visit stockanalysis.com
$11.28M
N/A
N/A
N/A
Imagion Biosystems Ltd (IBX) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at AUD0.02, down 21.74% from the previous close.
Over the past year, IBX has traded between a low of AUD0.01 and a high of AUD0.05. The stock has gained 38.5% over this period. It is currently 63.3% below its 52-week high.
Imagion Biosystems Ltd has a market capitalization of $11.28M.
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Side-by-side comparison against top Healthcare peers.